v3.25.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Assets [Abstract]    
Cash and cash equivalents $ 490,989 $ 377,099
Cash collateral posted to counterparties 332,818 244,440
Mortgage-backed securities (including pledged of $12,382,611 and $6,893,629, respectively), at fair value 13,230,145 7,512,087
Due from counterparties 25,255 10,445
Derivative assets 14,100 133
Accrued interest receivable 55,931 32,841
Other assets 9,456 7,534
Total assets 14,158,694 8,184,579
Liabilities:    
Repurchase agreements 11,753,522 6,563,120
Due to counterparties 270,719 341,924
Derivative liabilities 4,635 22,814
Cash collateral posted by counterparties 18,424 0
Accrued interest payable 110,517 44,672
Dividends payable 30,688 16,501
Other liabilities 12,641 10,612
 Total liabilities 12,201,146 6,999,643
Preferred Stock, Liquidation Preference, Value 111,500 111,500
Stockholders' Equity Attributable to Parent [Abstract]    
Preferred stock, par value $0.01 per share; 50,000,000 shares authorized; 4,460,000 and 4,460,000 shares issued and outstanding, respectively ($111,500 and $111,500 aggregate liquidation preference, respectively) 107,843 107,843
Common stock, par value $0.01 per share, 360,000,000 shares authorized; 145,714,136 and 84,491,800 shares issued and outstanding, respectively 1,457 845
Additional paid-in capital 2,524,286 1,742,471
Accumulated other comprehensive loss (134,069) (172,489)
Accumulated deficit (541,969) (493,734)
 Total shareholders’ equity 1,957,548 1,184,936
Total liabilities and shareholders’ equity $ 14,158,694 $ 8,184,579

Source

10-Q PDF XBRL Zip